Form 4 for SONM DNA X, Inc.
Accepted 2024-07-23 00:00:00 ET · period of report 2024-07-19 · accession 0001493152-24-028776 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-23 | 2024-07-19 | SONM | Wang Jeffrey | Dir, 10% | S - Sale | $3.67 | -1,623 | 25.8K | -6% | -$5,956 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-19 | S | D | 1,623 | $3.67 | 25,779 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.67, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. (F3) Consists of (i) 14,757 shares of common stock and (ii) 11,022 unvested restricted stock units. (F4) The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9. |